What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Stroke
- Surgery
Stroke, Internal medicine, Surgery, Randomized controlled trial and Cardiology are his primary areas of study.
His research integrates issues of Physical therapy and Tissue plasminogen activator in his study of Stroke.
His Physical therapy study combines topics in areas such as Vascular disease and Emergency medicine.
As part of his studies on Internal medicine, Geoffrey A. Donnan often connects relevant subjects like Placebo.
His Surgery research is multidisciplinary, incorporating perspectives in Clinical trial, Desmoteplase, Intensive care medicine, Meta-analysis and Intracerebral hemorrhage.
His Randomized controlled trial research incorporates elements of Translational research and Brain ischemia.
His most cited work include:
- COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS (3355 citations)
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials (2631 citations)
- Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) (2564 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Stroke, Internal medicine, Cardiology, Surgery and Thrombolysis.
His work carried out in the field of Stroke brings together such families of science as Physical therapy, Randomized controlled trial, Intensive care medicine and Clinical trial.
The Brain ischemia, Modified Rankin Scale, Odds ratio and Aspirin research he does as part of his general Internal medicine study is frequently linked to other disciplines of science, such as Clinical neurology, therefore creating a link between diverse domains of science.
Geoffrey A. Donnan combines subjects such as Placebo, Intracerebral hemorrhage and Risk factor with his study of Surgery.
The concepts of his Thrombolysis study are interwoven with issues in Anesthesia, Magnetic resonance imaging, Fibrinolytic agent, Perfusion scanning and Tissue plasminogen activator.
His study in Magnetic resonance imaging is interdisciplinary in nature, drawing from both Nuclear medicine and Penumbra.
He most often published in these fields:
- Stroke (70.50%)
- Internal medicine (34.74%)
- Cardiology (23.84%)
What were the highlights of his more recent work (between 2015-2021)?
- Stroke (70.50%)
- Internal medicine (34.74%)
- Thrombolysis (18.40%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Stroke, Internal medicine, Thrombolysis, Cardiology and Emergency medicine.
His Stroke research integrates issues from Odds ratio and Randomized controlled trial, Surgery.
He has included themes like Physical therapy and Clinical trial in his Randomized controlled trial study.
His research on Internal medicine frequently connects to adjacent areas such as Placebo.
The Thrombolysis study which covers Triage that intersects with Prehospital thrombolysis.
His research investigates the connection between Cardiology and topics such as Magnetic resonance imaging that intersect with problems in Nuclear medicine.
Between 2015 and 2021, his most popular works were:
- Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials (2631 citations)
- Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis (891 citations)
- Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly (354 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
